AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

At only age 28, the newlywed and busy teacher initially dismissed her symptoms. As her cough and fatigue worsened, she ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

Cancer is a complex condition marked by the uncontrolled growth of cells in the body. When this process begins in the lungs, ...

Englewood Health appointed Dr. Malay S. Rao as the new chief of radiation oncology at The Lefcourt Family Cancer Treatment ...

Discover the four vital indicators that your cancer treatment is effective, from tumor shrinkage to symptom relief, helping ...

More than 68 lakh cancer treatments worth over Rs 13,000 crore have been performed under the Ayushman Bharat health insurance scheme, with 75.81 per cent of them undertaken in rural areas, Union ...